Skip to content

Dr. Barry Dworkin

  • About
  • Radio Interviews
    • Wednesday House Call
    • Sunday House Call Shows
  • Articles
    • Health Headlines
    • Prevention and Screening
    • Clinical Research
    • Health Policy
    • Cancer/Oncology
    • Neurology
  • New recommendations to measure obesity are more helpful than using only body mass index or BMI

    January 22, 2025

    Medical Mythbusting Commentary for January 22, 2025 Source:BMI is wrong way to measure obesity, researchers say — here’s what they recommend instead

  • House Calls, #951, December 15, 2024: Eli Lilly Levies Fat Tax on Weight Loss Drug

    December 15, 2024

    Dr. Yoni Freedhoff joins me today to discuss the decision by Eli Lilly, manufacturer of Mounjaro, to charge more for patients who are suffering with the affects of obesity. In fact the cost will be double that of people using it for the treatment of their type 2 diabetes. Your Calls and Comments:

  • Having “skinny genes” does not imply that stable weight and health are a given. Nor did the study provide conclusive proof that they play a major role in weight stability.

    October 22, 2024

    Medical Mythbusting Commentary for October 22, 2024 Source:Does having ‘skinny genes’ mean you can skip exercise and diet? Reference:Genotypic Variations Associated with Changes in Body Mass in Response to Endurance Training

  • Researchers have found a genetic mutation for hypothyroidism that applies to 1/5000 people and that can lead to increased weight gain. Claims that it is a genetic link to obesity requires some jumping of the hoops.

    June 25, 2024

    Medical Mythbusting Commentary for June 25, 2024 Source:Researchers have found a ‘clear genetic trigger for obesity’ that applies to some people Reference: SMIM1 absence is associated with reduced energy expenditure and excess weight

  • Mothers with obesity at greater risk of stillbirth: Canadian study

    March 6, 2024

    Medical Mythbusting Commentary for March 6, 2024 Source:Mothers with obesity at greater risk of stillbirth: Canadian study Reference:The impact of isolated obesity compared with obesity and other risk factors on risk of stillbirth: a retrospective cohort study

  • Sunday House Call, #909, January 14, 2024: How health insurance company wanna-be-doctor bean counter’s medication-coverage decisions interfere with therapeutic management and has had a deleterious effect on (my) patients’ health outcomes.

    January 14, 2024

    I talked about this before yet this continues to be a major issue in that evidence-based medicine is being thwarted by insurance companies’ decision to not provide Semaglutide (Ozempic) for the treatment and management of obesity. It is having a deleterious effect both from a mental and physical health perspective on my patients. Wasn’t the…

  • Could a vibrating, ingestible capsule help treat obesity? Not likely due to logistical, physiological, lifestyle factors, and whether animal models are transferable to humans.

    January 3, 2024

    Medical Mythbusting Commentary for January 3, 2024 Source:Could a vibrating, ingestible capsule help treat obesity? Reference:A vibrating ingestible bioelectronic stimulator modulates gastric stretch receptors for illusory satiety

  • Sunday House Call, #902, November 19, 2023: The Chosen Ones.

    November 19, 2023

    How some pharmacies are deciding that people with type 2 diabetes supersede people with obesity respecting their prescriptions for Ozempic due to shortages. I discuss why this is completely unethical and how other pharmacies are staying away from this bad decision. Your Calls and Comments:

  • Obesity drug Wegovy cut risk of serious heart problems by 20 per cent, study finds

    November 13, 2023

    Medical Mythbusting Commentary for November 13, 2023 Source:Obesity drug Wegovy cut risk of serious heart problems by 20 per cent, study finds Reference:Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

  • Facebook
  • X

Notifications